BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 24280224)

  • 1. Intranuclear aggregation of mutant FUS/TLS as a molecular pathomechanism of amyotrophic lateral sclerosis.
    Nomura T; Watanabe S; Kaneko K; Yamanaka K; Nukina N; Furukawa Y
    J Biol Chem; 2014 Jan; 289(2):1192-202. PubMed ID: 24280224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis.
    Kwiatkowski TJ; Bosco DA; Leclerc AL; Tamrazian E; Vanderburg CR; Russ C; Davis A; Gilchrist J; Kasarskis EJ; Munsat T; Valdmanis P; Rouleau GA; Hosler BA; Cortelli P; de Jong PJ; Yoshinaga Y; Haines JL; Pericak-Vance MA; Yan J; Ticozzi N; Siddique T; McKenna-Yasek D; Sapp PC; Horvitz HR; Landers JE; Brown RH
    Science; 2009 Feb; 323(5918):1205-8. PubMed ID: 19251627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggregation of FET Proteins as a Pathological Change in Amyotrophic Lateral Sclerosis.
    Furukawa Y; Tokuda E
    Adv Exp Med Biol; 2017; 925():1-12. PubMed ID: 27311318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arginine methylation by PRMT1 regulates nuclear-cytoplasmic localization and toxicity of FUS/TLS harbouring ALS-linked mutations.
    Tradewell ML; Yu Z; Tibshirani M; Boulanger MC; Durham HD; Richard S
    Hum Mol Genet; 2012 Jan; 21(1):136-49. PubMed ID: 21965298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A yeast model of FUS/TLS-dependent cytotoxicity.
    Ju S; Tardiff DF; Han H; Divya K; Zhong Q; Maquat LE; Bosco DA; Hayward LJ; Brown RH; Lindquist S; Ringe D; Petsko GA
    PLoS Biol; 2011 Apr; 9(4):e1001052. PubMed ID: 21541368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FUS/TLS-immunoreactive neuronal and glial cell inclusions increase with disease duration in familial amyotrophic lateral sclerosis with an R521C FUS/TLS mutation.
    Suzuki N; Kato S; Kato M; Warita H; Mizuno H; Kato M; Shimakura N; Akiyama H; Kobayashi Z; Konno H; Aoki M
    J Neuropathol Exp Neurol; 2012 Sep; 71(9):779-88. PubMed ID: 22878663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant localization of FUS and TDP43 is associated with misfolding of SOD1 in amyotrophic lateral sclerosis.
    Pokrishevsky E; Grad LI; Yousefi M; Wang J; Mackenzie IR; Cashman NR
    PLoS One; 2012; 7(4):e35050. PubMed ID: 22493728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with a Global Methyltransferase Inhibitor Induces the Intranuclear Aggregation of ALS-Linked FUS Mutant In Vitro.
    Fujii S; Takanashi K; Kitajo K; Yamaguchi A
    Neurochem Res; 2016 Apr; 41(4):826-35. PubMed ID: 26603295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recruitment into stress granules prevents irreversible aggregation of FUS protein mislocalized to the cytoplasm.
    Shelkovnikova TA; Robinson HK; Connor-Robson N; Buchman VL
    Cell Cycle; 2013 Oct; 12(19):3194-202. PubMed ID: 24013423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Directly converted patient-specific induced neurons mirror the neuropathology of FUS with disrupted nuclear localization in amyotrophic lateral sclerosis.
    Lim SM; Choi WJ; Oh KW; Xue Y; Choi JY; Kim SH; Nahm M; Kim YE; Lee J; Noh MY; Lee S; Hwang S; Ki CS; Fu XD; Kim SH
    Mol Neurodegener; 2016 Jan; 11():8. PubMed ID: 26795035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ALS mutant FUS disrupts nuclear localization and sequesters wild-type FUS within cytoplasmic stress granules.
    Vance C; Scotter EL; Nishimura AL; Troakes C; Mitchell JC; Kathe C; Urwin H; Manser C; Miller CC; Hortobágyi T; Dragunow M; Rogelj B; Shaw CE
    Hum Mol Genet; 2013 Jul; 22(13):2676-88. PubMed ID: 23474818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import.
    Dormann D; Rodde R; Edbauer D; Bentmann E; Fischer I; Hruscha A; Than ME; Mackenzie IR; Capell A; Schmid B; Neumann M; Haass C
    EMBO J; 2010 Aug; 29(16):2841-57. PubMed ID: 20606625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FUS/TLS forms cytoplasmic aggregates, inhibits cell growth and interacts with TDP-43 in a yeast model of amyotrophic lateral sclerosis.
    Kryndushkin D; Wickner RB; Shewmaker F
    Protein Cell; 2011 Mar; 2(3):223-36. PubMed ID: 21452073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Widespread FUS mislocalization is a molecular hallmark of amyotrophic lateral sclerosis.
    Tyzack GE; Luisier R; Taha DM; Neeves J; Modic M; Mitchell JS; Meyer I; Greensmith L; Newcombe J; Ule J; Luscombe NM; Patani R
    Brain; 2019 Sep; 142(9):2572-2580. PubMed ID: 31368485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis.
    Deng HX; Zhai H; Bigio EH; Yan J; Fecto F; Ajroud K; Mishra M; Ajroud-Driss S; Heller S; Sufit R; Siddique N; Mugnaini E; Siddique T
    Ann Neurol; 2010 Jun; 67(6):739-48. PubMed ID: 20517935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggregation of ALS-linked FUS mutant sequesters RNA binding proteins and impairs RNA granules formation.
    Takanashi K; Yamaguchi A
    Biochem Biophys Res Commun; 2014 Sep; 452(3):600-7. PubMed ID: 25173930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fused in sarcoma (FUS) protein lacking nuclear localization signal (NLS) and major RNA binding motifs triggers proteinopathy and severe motor phenotype in transgenic mice.
    Shelkovnikova TA; Peters OM; Deykin AV; Connor-Robson N; Robinson H; Ustyugov AA; Bachurin SO; Ermolkevich TG; Goldman IL; Sadchikova ER; Kovrazhkina EA; Skvortsova VI; Ling SC; Da Cruz S; Parone PA; Buchman VL; Ninkina NN
    J Biol Chem; 2013 Aug; 288(35):25266-25274. PubMed ID: 23867462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6.
    Vance C; Rogelj B; Hortobágyi T; De Vos KJ; Nishimura AL; Sreedharan J; Hu X; Smith B; Ruddy D; Wright P; Ganesalingam J; Williams KL; Tripathi V; Al-Saraj S; Al-Chalabi A; Leigh PN; Blair IP; Nicholson G; de Belleroche J; Gallo JM; Miller CC; Shaw CE
    Science; 2009 Feb; 323(5918):1208-1211. PubMed ID: 19251628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA-binding ability of FUS regulates neurodegeneration, cytoplasmic mislocalization and incorporation into stress granules associated with FUS carrying ALS-linked mutations.
    Daigle JG; Lanson NA; Smith RB; Casci I; Maltare A; Monaghan J; Nichols CD; Kryndushkin D; Shewmaker F; Pandey UB
    Hum Mol Genet; 2013 Mar; 22(6):1193-205. PubMed ID: 23257289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear localization sequence of FUS and induction of stress granules by ALS mutants.
    Gal J; Zhang J; Kwinter DM; Zhai J; Jia H; Jia J; Zhu H
    Neurobiol Aging; 2011 Dec; 32(12):2323.e27-40. PubMed ID: 20674093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.